Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

September 25, 2023

Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes

New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant.

September 20, 2023

The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopha

September 19, 2023-September 30, 2023

The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) workshop highlights secondary use research that utilized

September 18, 2023

AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastruct

September 12, 2023

The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development. TUCSON, Ariz., Septe

September 11, 2023-September 13, 2023

Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will leave this 2.5

August 29, 2023

C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and the PKD Foundation will be hosting an Externally-Led Patient

August 25, 2023

Klaus Romero, Chief Science Officer at Critical Path Institute, occupies a rare role in the industry, as the top scientist in an o

August 25, 2023

AcureX is a pharmaceutical company on a mission to stop major neurodegenerative diseases before they start, with an

August 25, 2023

This memo outlines how C-Path can contribute as a key strategic regulatory partner to the Innovative Health Initiative’s (I